You are here

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Montgomery, Alabama, 36106 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Skin/Soft Tissue Infections, Methicillin Resistant Staphylococcus Aureus (MRSA)
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male and female subjects with signs or symptoms consistent with infection, and if
available, laboratory findings consistent with staphylococcal infection (e.g., Gram
stain and culture results).

- Signs and symptoms consistent with infection

- Infection suspected to be due to Methicillin Resistant Staphylococcus Aureus

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who were treated with a previous antibiotic (systemic or topical) with MRSA
activity (other than linezolid or vancomycin) for more than 24 hours and treatment
extended into the 72 hour period prior to the first dose of study drug, unless
documented to be a treatment failure (72 hours of treatment and not responding).

- Subjects with uncomplicated skin or superficial skin structure infection such as
superficial/simple cellulitis, impetiginous lesion, furuncle, or simple abscess that
only need surgical drainage for cure.

- Subjects excluded with necrotizing fasciitis, gas gangrene, osteomyelitis

NCT00087490
Pfizer
Completed
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now